Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals

来源 :World Journal of Gastrointestinal Oncology | 被引量 : 0次 | 上传用户:jicck321
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Pancreatic cancer(PC) is a major health problem. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. In addition,radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. , radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC.
其他文献
背景系统性红斑狼疮(systemic lupus erythematosus,SLE)是一种产生多种自身抗体、形成免疫复合物和攻击多系统脏器为特点的结缔组织病。其中肾脏受累率是最高的,约75%的患者